A second Italian survey examined the use of anti-IgE and anti-IL5 biological therapies in children/adolescents with severe allergic asthma and other forms of atopy during the pandemic period (20 participating centers, 308 asthmatic patients on biologic therapy, monitored between February and April 2020). This evidence concerns the gene IGHE and allergic asthma.